Epigral Ltd vs Srf Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 868 as of 18 Mar 11:42 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of SRF Ltd changed from 27.2 on March 2021 to 69.9 on March 2025 . This represents a CAGR of 20.78% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of SRF Ltd changed from ₹ 32030 crore on March 2021 to ₹ 87129 crore on March 2025 . This represents a CAGR of 22.16% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of SRF Ltd for the Dec '25 is ₹ 3739 crore as compare to the Sep '25 revenue of ₹ 3665 crore. This represent the growth of 2.02% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of SRF Ltd for the Dec '25 is ₹ 734.06 crore as compare to the Sep '25 ebitda of ₹ 799.86 crore. This represent the decline of -8.23% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of SRF Ltd changed from ₹ 252.22 crore to ₹ 432.66 crore over 7 quarters. This represents a CAGR of 36.12% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of SRF Ltd changed from 15.63 % on March 2021 to 16.89 % on March 2025 . This represents a CAGR of 1.56% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About SRF Ltd

SRF Limited is a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates.
The Company is a market leader in most of its business segments in India and overseas.
The Company has operations in four countries, India, Thailand, South Africa, and Hungary.
SRF has commercial interests in more than ninety countries and classifies its businesses as Technical Textiles Business (TTB), Chemicals Business (CB), Packaging Films Business (PFB), and Other Businesses.
The principal activities of the Company are manufacturing, purchase and sale of technical textiles, chemicals, packaging films and other polymers. SRF Limited (SRF) was incorporated on 9th January 1970 under the name of Shriram Fibres Ltd. The change in name of the Company was made in year 1990 from Shriram Fibres Limited to the present name SRF Limited.

FAQs for the comparison of Epigral Ltd and SRF Ltd

Which company has a larger market capitalization, Epigral Ltd or SRF Ltd?

Market cap of Epigral Ltd is 3,685 Cr while Market cap of SRF Ltd is 74,069 Cr

What are the key factors driving the stock performance of Epigral Ltd and SRF Ltd?

The stock performance of Epigral Ltd and SRF Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and SRF Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹854.2. On the other hand, SRF Ltd stock price is INR ₹2498.75.

How do dividend payouts of Epigral Ltd and SRF Ltd compare?

To compare the dividend payouts of Epigral Ltd and SRF Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.